Azenta Q4 2026 Revenue Rises 5%
Azenta reported Q4 2026 revenue growth of 5% with FY 2027 revenue guidance provided. The company recorded a net loss primarily due to the strategic divestiture of B Medical Systems.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed